These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7665848)

  • 1. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis.
    Bedossa P; Paradis V
    J Hepatol; 1995; 22(2 Suppl):37-42. PubMed ID: 7665848
    [No Abstract]   [Full Text] [Related]  

  • 2. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis.
    Meindl-Beinker NM; Dooley S
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S122-7. PubMed ID: 18336655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth.
    Wells RG; Kruglov E; Dranoff JA
    FEBS Lett; 2004 Feb; 559(1-3):107-10. PubMed ID: 14960316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta and liver regeneration: the stage may be set, but what's the script?
    Davis BH; Chen A
    Hepatology; 1996 Jun; 23(6):1703-5. PubMed ID: 8675198
    [No Abstract]   [Full Text] [Related]  

  • 5. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
    Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
    Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
    Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
    Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
    Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
    BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.
    Bruijn JA; Roos A; de Geus B; de Heer E
    J Lab Clin Med; 1994 Jan; 123(1):34-47. PubMed ID: 8288959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
    Breitkopf K; Lahme B; Tag CG; Gressner AM
    Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic fibrogenesis].
    Loréal O; Clément B; Deugnier Y
    Rev Prat; 1997 Mar; 47(5):482-6. PubMed ID: 9138408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
    Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
    Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling.
    Mazzieri R; Jurukovski V; Obata H; Sung J; Platt A; Annes E; Karaman-Jurukovska N; Gleizes PE; Rifkin DB
    J Cell Sci; 2005 May; 118(Pt 10):2177-87. PubMed ID: 15870109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis.
    Kim KH; Kim HC; Hwang MY; Oh HK; Lee TS; Chang YC; Song HJ; Won NH; Park KK
    Biochem Biophys Res Commun; 2006 May; 343(4):1072-8. PubMed ID: 16579972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta/Smad signaling in the injured liver.
    Breitkopf K; Godoy P; Ciuclan L; Singer MV; Dooley S
    Z Gastroenterol; 2006 Jan; 44(1):57-66. PubMed ID: 16397841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TGF-beta: usage in nephrology].
    Quirin N; Feige JJ; Zaoui P
    Nephrologie; 1996; 17(4):227-35. PubMed ID: 8768454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.
    Dudás J; Kovalszky I; Gallai M; Nagy JO; Schaff Z; Knittel T; Mehde M; Neubauer K; Szalay F; Ramadori G
    Am J Clin Pathol; 2001 May; 115(5):725-35. PubMed ID: 11345837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model.
    Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Tu DG; Hsieh HY
    J Ethnopharmacol; 2005 Feb; 97(1):7-13. PubMed ID: 15652268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
    Chegini N
    Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transforming growth factor-beta system and the kidney.
    Sharma K; Ziyadeh FN
    Semin Nephrol; 1993 Jan; 13(1):116-28. PubMed ID: 8381979
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
    Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
    Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.